Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBiocon

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Jindal Saw, Siemens, DLF; short Apollo Tyre

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Biocon, says Vishal Kshatriya

      Buy Biocon, says Vishal Kshatriya, Sr Derivative and Technical Analyst of Edelweiss.

    • Super Six trading ideas for the day

      On CNBC-TV18's in Super Six show, market gurus Rajesh Jain, EVP Retail Research of Religare Sec, Rakesh Gandhi, Sr Technical Analyst of LKP and Vishal Kshatriya, Sr Derivative and Technical Analyst of Edelweiss, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Short Biocon, says Jagannadham Thunuguntla

      Short Biocon, says Jagannadham Thunuguntla of SMC Global.

    • Bull's Eye: Buy ITC, Berger Paint, HDFC Bank; short IVRCL

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Biocon, says Parag Doctor

      Buy Biocon, says Parag Doctor of Motilal Oswal.

    • Super Six trading ideas for the day

      On CNBC-TV18's new show Super Six, market gurus Parag Doctor of Motilal Oswal, Arunesh Madan, Founder and Director of Augment Investment and Manas Jaiswal, Technical Analyst of Emkay, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Short LIC Housing Finance, says Shardul Kulkarni

      Short LIC Housing Finance, says Shardul Kulkarni of Angel Broking.

    • Short Biocon with target of Rs 335: Thunuguntla

      Short Biocon with target of Rs 335, says Jagannadham Thunuguntla, Head of Research, SMC Global.

    • 12 trading strategies for intra-day

      In an interview to CNBC-TV18, Sharmila Joshi of Fairwealth Securities; Sanjay Vaid of SBI Capital Securities and Jagannadham Thunuguntla, Head of Research, SMC Global, share their stock strategies for intra-day trade.

    • Hold Biocon, says Nirav Vakharia

      Nirav Vakharia of Globe Capital advises to hold Biocon.

    • Buy pharma stocks: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas has recommended investing in pharma stocks.

    • Bull's Eye: 12 trading bets to boost your portfolio

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Biocon has target of Rs 390: DD Sharma

      Biocon has target of Rs 390, says DD Sharma, Senior Vice President Research, Anand Rathi.

    • Bull's Eye: 12 trading picks for safe return

      CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Biocon around Rs 365: Hemen Kapadia

      Buy Biocon around Rs 365, says Hemen Kapadia, chartpundit.com.

    • Super Six: Top chart picks for July 7

      On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia of chartpundit.com, Hemant Thukral of SBI Capital Securities and Arunesh Madan of Augment Investment, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Biocon has target of Rs 385: Shrikant Chauhan

      Biocon has target of Rs 385, says Shrikant Chauhan, Kotak Securities.

    • Super Six: Top chart picks for the day

      On CNBC-TV18's new show Super Six, market gurus Parag Doctor of Motilal Oswal Securities, Hemen Kapadia of chartpundit.com and Shrikant Chauhan of Kotak Securities, place their bets on two stocks each.

    • Lupin has target of Rs 530: Pankaj Pandey

      Lupin has target of Rs 530, says Pankaj Pandey, Head of Research, ICICI Direct.

    • Biocon may test Rs 388: Diwan

      Biocon may test Rs 388, says Prakash Diwan of Networth Stock Broking.

    • Bull's Eye: 12 must-have stocks for your portfolio

      Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

    • Sell Biocon, HPCL, Rel Cap, Grasim: SMC Global

      In an interview with CNBC Awaaz, Nitin Murarka of SMC Global has recommended selling Biocon, HPCL, Reliance Capital and Grasim Industries.

    • Biocon a defensive bet: Thununguntla

      Biocon a defensive bet says Jagannadham Thununguntla, Head of Research, SMC Global.

    • Bull's Eye: Stocks must have in your portfolio

      Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347